Suppr超能文献

早期霍奇金淋巴瘤预后因素分析

An analysis of prognostic factors in early stage Hodgkin's disease.

作者信息

Horwich A, Easton D, Nogueira-Costa R, Liew K H, Colman M, Peckham M J

出版信息

Radiother Oncol. 1986 Oct;7(2):95-106. doi: 10.1016/s0167-8140(86)80089-5.

Abstract

An analysis of prognostic factors has been carried out in 398 patients presenting with clinical Stage I and II Hodgkin's disease treated between 1963 and 1979. By life table analysis older age, lymphocyte depletion histology, systemic symptoms, mediastinal node bulk, and erythrocyte sedimentation rate (ESR) greater than 40 mm/h were associated with a significantly worse survival probability. On multiple factor regression analysis only age and stage were independent prognostic variables for survival, with systemic symptoms having borderline significance. Using this information, together with other analyses of prognosis in early Hodgkin's disease three groups of patients are defined. The first with a predicted 5-year survival of 78% would include patients possessing at least one of the following features; age greater than 60, lymphocyte depletion, greater than 3 sites involved, systemic symptoms, mediastinal/thoracic ratio of greater than 1/3. The second groups present with at least two of the following factors; ESR greater than 40 mm/h, male sex, 3 involved sites, or mixed cellularity histology, and the 5 year survival probability is 84%. The remaining Stage I and II patients would constitute a good prognosis group with a predicted 5-year survival of 92%.

摘要

对1963年至1979年间接受治疗的398例临床I期和II期霍奇金病患者的预后因素进行了分析。通过生命表分析,年龄较大、淋巴细胞消减型组织学、全身症状、纵隔淋巴结肿大以及红细胞沉降率(ESR)大于40mm/h与显著较差的生存概率相关。在多因素回归分析中,只有年龄和分期是生存的独立预后变量,全身症状具有临界显著性。利用这些信息,结合早期霍奇金病预后的其他分析,定义了三组患者。第一组预计5年生存率为78%,包括具有以下至少一项特征的患者:年龄大于60岁、淋巴细胞消减、累及部位超过3个、全身症状、纵隔/胸廓比值大于1/3。第二组具有以下至少两项因素:ESR大于40mm/h、男性、累及3个部位或混合细胞型组织学,5年生存概率为84%。其余的I期和II期患者将构成预后良好的组,预计5年生存率为92%。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验